Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
BDRXBiodexa Pharmaceuticals Plc
| Figure | BDRXBiodexa Pharmaceuticals PlcFY2023 · Dec |
|---|---|
| Revenue | $381.00K |
| Revenue, yoy | −45.5% |
| Net income | $6.38M |
| Net income, yoy | −11.4% |
| Net margin | — |
| Free cash flow | $5.59M |
| FCF margin | — |
| EPS, diluted | $0.00 |
Add another company.
Annual · FY2019–FY2023 · USD
From SEC EDGARSame fiscal periods, as filed